We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.40 | 1.24% | 195.40 | 194.80 | 195.60 | 195.60 | 192.00 | 192.40 | 342,131 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 26.67 | 424M |
TIDMAMS
RNS Number : 8760A
Advanced Medical Solutions Grp PLC
01 October 2015
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------ 1. Identity of the issuer or the underlying Advanced Medical Solutions Group issuer plc of existing shares to which voting rights are attached: (ii) ----------------------------------------------------- ----------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ü --------------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights --------------------------------------------------------------------------------- ------- Other (please specify): ------------------- ------------------------------------------------------------ ------- 3. Full name of person(s) subject Octopus Investments Nominees Limited to the notification obligation: (iii) -------------------------------------------- -------------------------------------------- 4. Full name of shareholder(s) n/a (if different from 3.):(iv) -------------------------------------------- -------------------------------------------- 5. Date of the transaction and date 18/09/2015 on which the threshold is crossed or reached: (v) -------------------------------------------- -------------------------------------------- 6. Date on which issuer notified: 30/09/2015 -------------------------------------------- -------------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 7% -------------------------------------------- -------------------------------------------- 8. Notified details: n/a ------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- ------------------------------------- ------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ------------- --------------- -------------------- ----------- ----------------------- ----------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----- ------ ------- ------ --- ----------- ------------ --------- ------------- -------------- GB0004536594 14485548 14485548 14609898 14609898 7% --------------- -------------------- ----------- ------------ --------- ------------- -------------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ---------------------- --------------- ----------------------------- --------------------------- -------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) --------------- ------------- --------------- ---------------- --------------------------- ------------------------- Nominal Delta --------------- ------------- --------------- ---------------- --------------------------- ------------ ----------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------------------- -------------------------------------------------------- 14609898 7% --------------------------------------------------------------- -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------- n/a Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: n/a --------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will n/a cease to hold: --------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to n/a hold voting rights: --------------------------------------------------- --------------------------- 13. Additional information: ---------------------------------------- -------------------------------------- 14. Contact name: Niki Read ---------------------------------------- -------------------------------------- 15. Contact telephone number: 020 7776 7969 ---------------------------------------- -------------------------------------- Note: Annex should only be submitted to the FCA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation -------------------------------------------------------------------------- Full name Peter Orsi (including legal form of legal entities) ------------------------------------------- ----------------------------- Contact address 33 Holborn, London, EC1N 2HT (registered office for legal entities) ------------------------------------------- ----------------------------- Phone number & email 020 7710 2877 ------------------------------------------- ----------------------------- Other useful information (at least legal representative for legal persons) ------------------------------------------- ----------------------------- B: Identity of the notifier, if applicable -------------------------------------------------------------------------- Full name ------------------------------------------- ----------------------------- Contact address ------------------------------------------- ----------------------------- Phone number & email ------------------------------------------- ----------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------------- ----------------------------- C: Additional information -------------------------------------------------------------------------- For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
(MORE TO FOLLOW) Dow Jones Newswires
October 01, 2015 03:43 ET (07:43 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions